Intravascular Lithotripsy Market Size

  • Report ID: 5366
  • Published Date: Aug 31, 2026
  • Report Format: PDF, PPT

Intravascular Lithotripsy Market Outlook:

Intravascular Lithotripsy Market size was valued at USD 1.15 billion in 2026 and is projected to reach USD 4.86 billion by the end of 2036, registering around 15.5% CAGR during the forecast period, i.e., 2027-2036. In 2027, the industry size of intravascular lithotripsy is assessed at USD 1.33 billion.

The growth of this market can be attributed on the account of growing prevalence of cardiovascular diseases all across the globe. Cardiovascular diseases, such as coronary heart disease and peripheral artery disease, are increasing worldwide due to unhealthy lifestyles, changes in dietary habits and aging populations. This has increased the need for effective treatments and minimally invasive procedures such as angioplasty or stenting, thus raising the demand for intravascular lithotripsy. According to WHO, cardiovascular disease is the leading cause of death worldwide, with about 17.9 million deaths each year.

Furthermore, the escalating existence of complexities associated with kidney stones is the main factor driving the market expansion of intravascular lithotripsy. Besides, the growing adoption of intravascular lithotripsy in order to treat patients with coronary artery disease and constant ongoing research and development in intravascular lithotripsy further is positively influencing the market growth in the projected time frame. 


INTRAVASCULAR LITHOTRIPSY Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of the intravascular lithotripsy was over USD 1.15 billion.

The global intravascular lithotripsy sector registered a profitable valuation of USD 1.15 billion in 2026 and is poised to reach USD 4.86 billion by 2036, expanding at a CAGR of 15.5% during the forecast period, i.e., 2027-2036.

The North America intravascular lithotripsy market is expected to capture 35% share by 2036, driven by favorable reimbursement policies and rapid adoption of technological developments.

Key players in the market include Abbott Laboratories, Siemens AG, Olympus America, Boston Scientific, Medispec Ltd, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc..
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos